COVID-19, myocarditis and pericarditis
DL Fairweather, DJ Beetler, DN Di Florio… - Circulation …, 2023 - Am Heart Assoc
Viral infections are a leading cause of myocarditis and pericarditis worldwide, conditions that
frequently coexist. Myocarditis and pericarditis were some of the early comorbidities …
frequently coexist. Myocarditis and pericarditis were some of the early comorbidities …
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
The persistent COVID-19 pandemic since 2020 has brought an enormous public health
burden to the global society and is accompanied by various evolution of the virus genome …
burden to the global society and is accompanied by various evolution of the virus genome …
ACE2-independent alternative receptors for SARS-CoV-2
S Lim, M Zhang, TL Chang - Viruses, 2022 - mdpi.com
Severe acute respiratory syndrome-related coronavirus (SARS-CoV-2), the causative agent
of coronavirus disease 2019 (COVID-19), is highly contagious and remains a major public …
of coronavirus disease 2019 (COVID-19), is highly contagious and remains a major public …
Long COVID: a review and proposed visualization of the complexity of long COVID
Post-Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus–2 (SARS-CoV-2)
infection, or Long COVID, is a prevailing second pandemic with nearly 100 million affected …
infection, or Long COVID, is a prevailing second pandemic with nearly 100 million affected …
COVID-19 and the vasculature: current aspects and long-term consequences
B Martinez-Salazar, M Holwerda, C Stuedle… - Frontiers in cell and …, 2022 - frontiersin.org
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was first identified in
December 2019 as a novel respiratory pathogen and is the causative agent of Corona Virus …
December 2019 as a novel respiratory pathogen and is the causative agent of Corona Virus …
COVID-19 infection: an overview on cytokine storm and related interventions
Abstract Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) has posed a significant threat to global health. This …
syndrome coronavirus-2 (SARS-CoV-2) has posed a significant threat to global health. This …
Post-COVID syndrome, inflammation, and diabetes
AA Rizvi, A Kathuria, W Al Mahmeed… - Journal of Diabetes and …, 2022 - Elsevier
The raging COVID-19 pandemic is in its third year of global impact. The SARS CoV 2 virus
has a high rate of spread, protean manifestations, and a high morbidity and mortality in …
has a high rate of spread, protean manifestations, and a high morbidity and mortality in …
Advances in nanomaterial-based platforms to combat COVID-19: Diagnostics, preventions, therapeutics, and vaccine developments
The COVID-19 pandemic caused by the SARS-CoV-2, a ribonucleic acid (RNA) virus that
emerged less than two years ago but has caused nearly 6.1 million deaths to date. Recently …
emerged less than two years ago but has caused nearly 6.1 million deaths to date. Recently …
Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases
S Ashique, G De Rubis, E Sirohi, N Mishra… - Chemico-biological …, 2022 - Elsevier
The human microbiota is fundamental to correct immune system development and balance.
Dysbiosis, or microbial content alteration in the gut and respiratory tract, is associated with …
Dysbiosis, or microbial content alteration in the gut and respiratory tract, is associated with …
Macrophage ACE2 is necessary for SARS-CoV-2 replication and subsequent cytokine responses that restrict continued virion release
LI Labzin, KY Chew, K Eschke, X Wang, T Esposito… - Science …, 2023 - science.org
Macrophages are key cellular contributors to the pathogenesis of COVID-19, the disease
caused by the virus SARS-CoV-2. The SARS-CoV-2 entry receptor ACE2 is present only on …
caused by the virus SARS-CoV-2. The SARS-CoV-2 entry receptor ACE2 is present only on …